CVRx, Inc.CVRXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-93.5%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-93.5%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20250.01%
2024-4.32%
202316.89%
202232.68%
202117.02%
2020-26.00%
20190.00%